Foundayo, another GLP-1 medication, recently approved, offers convenient daily dosing
The research suggests that approximately 22.4% of people on GLP-1 class medications develop nutritional deficiencies within 12 months, which is one reason regular blood monitoring is recommended throughout treatment
Calorie and hydration concerns during breastfeeding Beyond the direct medication transfer question, there is a practical concern about caloric intake
Taken together, the findings based on polling of more than 2,000 UK shoppers suggest GLP-1 drugs are not simply reducing appetite they are reshaping taste and consumption habits, posing a longer-term challenge to categories built around indulgence, snacking and large portion sizes
In this post, well explore what it is, how it works, clinical data, and what makes it a major step forward in weight-loss science